Recent news on Sufentanil

Labtec's Next Generation Pain Patch Successful in Clinical Studies  -  Apr 27, 2007
Emediawire (press release),..."Today, we are pleased to announce the successful completion of the second clinical trial for our Sufentanil TDS®. Our goal for this program was to complete

DURECT Corporation Announces First Quarter 2007 Financial Results  -  May 7, 2007
PR Newswire (press release),TRANSDUR(TM)-Sufentanil. TRANSDUR-Sufentanil is our proprietary transdermal patch intended to provide sufentanil for a period of up to seven days from a

Scientists Probe Ways to Curb Opioid Abuse Without Hindering Pain ...  -  May 8, 2007
Journal of American Medical Association (subscription),Palmer has worked with AcelRX Pharmaceuticals Inc, based in Redwood City, Calif, to develop a tiny sublingual sufentanil pill that has more than 90%

Labtec’s Next Generation Pain Patch Successful in Clinical Studies  -  26 Apr 2007
PharmaLive.com (press release),...“Today, we are pleased to announce the successful completion of the second clinical trial for our Sufentanil TDS®. Our goal for this program was to complete

DURECT Corporation Announces Fourth Quarter and Year End 2006 ...  -  Feb 8, 2007
PR Newswire (press release),TRANSDUR-Sufentanil. During 2006, our main activity under this program involved supply of product for on-going clinical and non- clinical studies conducted

Endo releases 2007 earnings guidance  -  Jan 8, 2007
BusinessWeekThe majority of research and development spending will go toward ongoing clinical trials for Rapinyl, the topical ketoprofen patch, a transdermal sufentanil

Endo Pharmaceuticals Provides Financial Guidance for 2007  -  Jan 9, 2007
PharmaLive.com (press release),...the topical ketoprofen patch, the transdermal sufentanil patch and EN3285, its oral rinse for the treatment of oral mucositis obtained through the

DURECT Corporation Announces Third Quarter 2006 Financial Results  Nov 3, 2006
The active pharmaceutical ingredient in the new ORADUR-based opioid drug candidate has not been disclosed. -- TRANSDUR Sufentanil Patch. ... -Yahoo! News (press release) WR Hambrecht Defends Endo Pharma (ENDP), Says Could Be a Good Fit ...  Oct 18, 2006
...firm said, "assuming a worst case Paragraph IV patent challenge, the earliest a generic could hit would be 2009 and by then, transdermal sufentanil patch-seven ... -StreetInsider.com (subscription), Addiction on call  Sep 3, 2006
The anesthetic sufentanil is 5 to 10 times more potent than fentanyl, and a user can become addicted in just two or three weeks, said Dr. William Arnold III ... -Chicago Sun-Times

DURECT Corporation Announces Second Quarter 2006 Financial Results  Jul 27, 2006
...in 2005, which included a $10.0 million payment from Endo Pharmaceuticals in connection with our license agreement for the TRANSDUR(TM)-Sufentanil product for ... -MSN Money

The New America  Aug 4, 2006
Co. sees potential in another drug in Endo's pipeline. He calls pain patch Sufentanil Endo's "real crown jewel.". The transdermal ... -Investor's Business Daily (subscription)

Labtec Begins Phase I Trials for Seven Day Transdermal Sufentanil ...  Jul 12, 2006
German-based Labtec GmbH has developed Sufentanil TDS, a transdermal patch designed for management of moderate to severe chronic pain. ... -PR Web



Endo Pharmaceuticals Reports First Quarter 2006 Financial Results  Apr 20, 2006
Add: Stock compensation expense related to SFAS 123R 2,323 - Add: Topical ketoprofen patch upfront payment - 10,000 Add: Transdermal sufentanil patch upfront ... - PR Newswire





DURECT Corporation Announces Anticipated Development Program ...  Feb 8, 2006
Transdermal Sufentanil Development Product (US collaboration with Endo Pharmaceuticals) * Our transdermal sufentanil patch (significantly smaller than the size ... - PR Newswire,

DURECT Corporation Reports Fourth Quarter and Year End 2005 ...  Feb 8, 2006
...technology. Pain Therapeutics, Inc. sub-licensed to King. transdermal sufentanil patch. In addition, we established a. development ... - PharmaLive.com,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional